Insider Transactions in Q1 2025 at Globe Life Inc. (GL)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 04
2025
|
Robert Edward Hensley EVP & Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
1,610
-13.64%
|
$199,640
$124.81 P/Share
|
Mar 03
2025
|
Philip M Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+50.0%
|
-
|
Mar 03
2025
|
Matthew J Adams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+50.0%
|
-
|
Feb 28
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,220
+28.64%
|
-
|
Feb 28
2025
|
Rebecca E Zorn EVP & Chief Talent Officer |
BUY
Grant, award, or other acquisition
|
Direct |
980
+6.7%
|
-
|
Feb 28
2025
|
Dolores L Skarjune EVP and Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,205
+12.82%
|
-
|
Feb 28
2025
|
Christopher Kyle Tyler EVP and Chief Info Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,125
+17.66%
|
-
|
Feb 28
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,686
+11.0%
|
-
|
Feb 28
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,310
+13.96%
|
-
|
Feb 28
2025
|
Michael Clay Majors EVP - Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,385
+2.86%
|
-
|
Feb 28
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,055
+5.69%
|
-
|
Feb 28
2025
|
Robert Edward Hensley EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+9.85%
|
-
|
Feb 28
2025
|
James Matthew Darden Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,686
+6.89%
|
-
|
Feb 26
2025
|
Rebecca E Zorn EVP & Chief Talent Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,746
-12.11%
|
$211,266
$121.93 P/Share
|
Feb 26
2025
|
Rebecca E Zorn EVP & Chief Talent Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,307
+23.01%
|
-
|
Feb 26
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,662
-15.14%
|
$564,102
$121.93 P/Share
|
Feb 26
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,845
+27.78%
|
-
|
Feb 26
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,755
-28.94%
|
$333,355
$121.93 P/Share
|
Feb 26
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Grant, award, or other acquisition
|
Direct |
6,999
+42.37%
|
-
|
Feb 26
2025
|
Michael Clay Majors EVP - Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,007
-6.18%
|
$363,847
$121.93 P/Share
|
Feb 26
2025
|
Michael Clay Majors EVP - Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,537
+13.41%
|
-
|
Feb 26
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,907
-10.4%
|
$230,747
$121.93 P/Share
|
Feb 26
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,846
+20.91%
|
-
|
Feb 26
2025
|
Robert Edward Hensley EVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,161
-17.05%
|
$261,481
$121.93 P/Share
|
Feb 26
2025
|
Robert Edward Hensley EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,384
+29.82%
|
-
|
Feb 26
2025
|
James Matthew Darden Co-Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,662
-9.17%
|
$564,102
$121.93 P/Share
|
Feb 26
2025
|
James Matthew Darden Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,845
+18.9%
|
-
|
Feb 26
2025
|
Thomas Peter Kalmbach EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,004
-11.63%
|
$363,484
$121.93 P/Share
|
Feb 26
2025
|
Thomas Peter Kalmbach EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,537
+22.6%
|
-
|
Feb 14
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,750
-19.68%
|
$1,311,500
$122.76 P/Share
|
Feb 14
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,750
+26.58%
|
$935,250
$87.6 P/Share
|
Feb 13
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
11,000
-36.73%
|
$1,342,000
$122.31 P/Share
|
Feb 13
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+26.86%
|
$957,000
$87.6 P/Share
|
Feb 11
2025
|
James Matthew Darden Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
24,890
-21.77%
|
$3,011,690
$121.63 P/Share
|
Feb 11
2025
|
James Matthew Darden Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,890
+28.04%
|
$2,165,430
$87.6 P/Share
|
Feb 11
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
11,000
-19.99%
|
$1,331,000
$121.67 P/Share
|
Feb 11
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+26.86%
|
$957,000
$87.6 P/Share
|
Feb 07
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,650
-47.09%
|
$1,299,300
$122.54 P/Share
|
Feb 07
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,650
+37.15%
|
$1,065,000
$100.78 P/Share
|
Feb 07
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Open market or private sale
|
Direct |
30,000
-59.56%
|
$3,630,000
$121.8 P/Share
|
Feb 07
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+47.98%
|
$2,460,000
$82.56 P/Share
|
Jan 06
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
13,448
-23.4%
|
$1,506,176
$112.7 P/Share
|
Jan 06
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+33.06%
|
$1,392,000
$87.6 P/Share
|
Jan 06
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,500
-45.18%
|
$168,000
$112.32 P/Share
|
Jan 06
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+31.12%
|
$147,000
$98.32 P/Share
|
Jan 06
2025
|
Mark A Blinn Director |
SELL
Open market or private sale
|
Direct |
3,000
-36.94%
|
$339,000
$113.23 P/Share
|
Jan 06
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
9,000
-22.53%
|
$1,008,000
$112.92 P/Share
|
Jan 06
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+28.59%
|
$477,000
$53.61 P/Share
|
Jan 02
2025
|
Mary E Thigpen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,604
+8.5%
|
-
|
Jan 02
2025
|
Cheryl Alston Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,604
+14.56%
|
-
|